Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Drug-resistant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03403907
What this trial is testing

The Effect of Probiotic Supplementation in Drug-resistant Epilepsy Patients

Who this might be right for
EpilepsyEpilepsy Intractable
María Gómez Eguílaz 45
Not applicableWithdrawnNCT04753983
What this trial is testing

Evaluate fMRI of Active DBS Stimulation in Epilepsy

Who this might be right for
Refractory Epilepsy
Mayo Clinic
Not applicableNot Yet RecruitingNCT07692477
What this trial is testing

Molecular Characterization of Tumor-Microenvironment Interactions to Predict Drug Resistance in Gastric and GEJ Adenocarcinoma

Who this might be right for
Gastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma (Siewert II-III)
Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis 250
Post-approval studies (Phase 4)Study completedNCT04504175
What this trial is testing

Ketamine for Older Adults Pilot

Who this might be right for
Treatment Resistant DepressionRefractory DepressionTherapy-Resistant Depression+2 more
Washington University School of Medicine 25
Testing effectiveness (Phase 2)UnknownNCT03765775
What this trial is testing

Anlotinib Plus Sintilimab for NSCLC Patients With First-generation EGFR-TKIs Drug Resistance Along With T790M Negative

Who this might be right for
CarcinomaNon-small Cell Lung CancerLung Neoplasm
First Hospital of Shijiazhuang City 20
Very early researchLooking for participantsNCT07507201
What this trial is testing

Allogeneic CD19/BCMA CAR-T for B Cell-Related Autoimmune Disease

Who this might be right for
Autoimmune DiseasesSystemic Lupus Erthematosus (SLE)Multi-Drug Resistant Nephrotic Syndrome+3 more
The Children's Hospital of Zhejiang University School of Medicine 15
Large-scale testing (Phase 3)Study completedNCT01597973
What this trial is testing

Trial for the Treatment of Extensively Drug-Resistant Gram-negative Bacilli (OVERCOME)

Who this might be right for
PneumoniaBlood Stream Infection
University of Michigan 467
Early research (Phase 1)Study completedNCT04309656
What this trial is testing

Single-dose Study in Two Panels of Healthy Adult Participants to Assess Immediate-Release and Dispersible Formulations of Pretomanid

Who this might be right for
Multi-drug Resistant Tuberculosis
Global Alliance for TB Drug Development 48
Not applicableLooking for participantsNCT05947656
What this trial is testing

Evaluation of the NaviFUS System in Drug Resistant Epilepsy

Who this might be right for
Epilepsy, Temporal LobeDrug Resistant Epilepsy
Genovate-NaviFUS (Australia) Pty Ltd. 18
Large-scale testing (Phase 3)Study completedNCT02983188
What this trial is testing

Berberine as Adjuvant Treatment for Schizophrenia Patients

Who this might be right for
SchizophreniaSchizophrenia Spectrum and Other Psychotic DisordersMetabolic Syndrome x
The University of Hong Kong 113
Not applicableStudy completedNCT01039480
What this trial is testing

Aspirin and Clopidogrel Resistance Study

Who this might be right for
Drug Resistance
University Hospital, Basel, Switzerland 82
Not applicableStudy completedNCT00695825
What this trial is testing

Effects the Glycemic Index on Metabolic Risk Markers

Who this might be right for
Metabolic Syndrome X
Maastricht University Medical Center 30
Post-approval studies (Phase 4)UnknownNCT05979896
What this trial is testing

Chemoprevention Efficacy Study Nigeria

Who this might be right for
Malaria
Malaria Consortium 800
Large-scale testing (Phase 3)Study completedNCT00162682
What this trial is testing

Monitoring Highly Active Antiretroviral Therapy in HIV-infected Parents in Thailand

Who this might be right for
HIV Infections
Institut de Recherche pour le Developpement 716
Early research (Phase 1)Study completedNCT02565862
What this trial is testing

A Drug-drug Interaction Study Between Daclatasvir and Metformin

Who this might be right for
Hepatitis CDiabetes MellitusInsulin Resistance
Radboud University Medical Center 20
Testing effectiveness (Phase 2)Looking for participantsNCT05791396
What this trial is testing

FMT to Eradicate Intestinal Colonization by Carbapenem-resistant Enterobacteriaceae

Who this might be right for
Enterobacteriaceae InfectionsMulti-antibiotic Resistance
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 36
Testing effectiveness (Phase 2)Study completedNCT00425113
What this trial is testing

Metronidazole for Pulmonary Tuberculosis (South Korea)

Who this might be right for
TuberculosisMulti-Drug Resistant Tuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 35
Early research (Phase 1)Study completedNCT04150224
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Food Effects Study of PBTZ169

Who this might be right for
Healthy Subjects
Nearmedic Plus LLC 60
Early research (Phase 1)Ended earlyNCT03799003
What this trial is testing

ASP1951 in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Astellas Pharma Global Development, Inc. 119
Not applicableEnded earlyNCT04398667
What this trial is testing

European Non-interventional Study on Refractory Epilepsy With Developmental Delay

Who this might be right for
Refractory EpilepsyDevelopment Delay
Zogenix, Inc. 93
Next Page